294 related articles for article (PubMed ID: 17633978)
1. [Myocardial ischaemia as a result of treatment with capecitabine].
van Halteren HK; Liem AH; Planting AS
Ned Tijdschr Geneeskd; 2007 Jun; 151(26):1469-73. PubMed ID: 17633978
[TBL] [Abstract][Full Text] [Related]
2. [Myocardial ischaemia as a result of treatment with capecitabine].
van der Vliet HJ; Kuenen BC
Ned Tijdschr Geneeskd; 2007 Sep; 151(36):2016; author reply 2016. PubMed ID: 17953177
[No Abstract] [Full Text] [Related]
3. Coronary spasm induced by capecitabine mimicks ST elevation myocardial infarction.
Scott PA; Ferchow L; Hobson A; Curzen NP
Emerg Med J; 2008 Oct; 25(10):699-700. PubMed ID: 18843078
[TBL] [Abstract][Full Text] [Related]
4. Capecitabine may induce coronary artery vasospasm.
Tsiamis E; Synetos A; Stefanadis C
Hellenic J Cardiol; 2012; 53(4):320-3. PubMed ID: 22796820
[TBL] [Abstract][Full Text] [Related]
5. [A case of toxicity caused by drug interaction between capecitabine and phenytoin in patient with colorectal cancer].
Sakurai M; Kawahara K; Ueda R; Fukui E; Yamada R
Gan To Kagaku Ryoho; 2011 May; 38(5):841-3. PubMed ID: 21566450
[TBL] [Abstract][Full Text] [Related]
6. Capecitabine induced cardiotoxicity: a case report and review of literature.
Tunio MA; Hashmi A; Shoaib M
Pak J Pharm Sci; 2012 Jan; 25(1):277-81. PubMed ID: 22186341
[TBL] [Abstract][Full Text] [Related]
7. Capecitabine in the management of colorectal cancer.
Maroun JA
Expert Rev Anticancer Ther; 2001 Oct; 1(3):327-33. PubMed ID: 12113099
[TBL] [Abstract][Full Text] [Related]
8. Capecitabine in the treatment of colorectal cancer.
Kelly C; Cassidy J
Expert Rev Anticancer Ther; 2007 Jun; 7(6):803-10. PubMed ID: 17555390
[TBL] [Abstract][Full Text] [Related]
9. Ventricular fibrillation as a likely consequence of capecitabine-induced coronary vasospasm.
Shah NR; Shah A; Rather A
J Oncol Pharm Pract; 2012 Mar; 18(1):132-5. PubMed ID: 21321041
[TBL] [Abstract][Full Text] [Related]
10. The use of raltitrexed (tomudex) in a patient with 5-fluorouracil induced myocardial ischaemia.
Nutting C; Folkes A
Clin Oncol (R Coll Radiol); 1999; 11(1):66. PubMed ID: 10194593
[No Abstract] [Full Text] [Related]
11. Coronary artery spasm induced by capecitabine.
Sestito A; Sgueglia GA; Pozzo C; Cassano A; Barone C; Crea F; Lanza GA
J Cardiovasc Med (Hagerstown); 2006 Feb; 7(2):136-8. PubMed ID: 16645374
[TBL] [Abstract][Full Text] [Related]
12. [The prevention of diarrhea while under capecitabine therapy].
Grouls V
Dtsch Med Wochenschr; 2008 Aug; 133(34-35):1750. PubMed ID: 18696410
[No Abstract] [Full Text] [Related]
13. Uncontrolled hypertriglyceridemia induced by capecitabine: case report and review of the literature.
Bar-Sela G; Haim N
Cancer Chemother Pharmacol; 2009 Apr; 63(5):779-82. PubMed ID: 18641989
[TBL] [Abstract][Full Text] [Related]
14. Capecitabine-induced severe hypertriglyceridemia: report of two cases.
Kurt M; Babaoglu MO; Yasar U; Shorbagi A; Guler N
Ann Pharmacother; 2006 Feb; 40(2):328-31. PubMed ID: 16391007
[TBL] [Abstract][Full Text] [Related]
15. Alternative treatment options in colorectal cancer patients with 5-fluorouracil- or capecitabine-induced cardiotoxicity.
Deboever G; Hiltrop N; Cool M; Lambrecht G
Clin Colorectal Cancer; 2013 Mar; 12(1):8-14. PubMed ID: 23102544
[TBL] [Abstract][Full Text] [Related]
16. Pharmacology and therapeutic efficacy of capecitabine: focus on breast and colorectal cancer.
Aprile G; Mazzer M; Moroso S; Puglisi F
Anticancer Drugs; 2009 Apr; 20(4):217-29. PubMed ID: 19247178
[TBL] [Abstract][Full Text] [Related]
17. Costs associated with capecitabine or 5-fluorouracil monotherapy after surgical resection in patients with colorectal cancer.
Chu E; Shi N; Wei W; Bendell JC; Cartwright T
Oncology; 2009; 77(3-4):244-53. PubMed ID: 19738390
[TBL] [Abstract][Full Text] [Related]
18. Toxic encephalopathy in elderly patients during treatment with capecitabine: literature review and a case report.
Fantini M; Gianni L; Tassinari D; Nicoletti S; Possenti C; Drudi F; Sintini M; Bagli L; Tamburini E; Ravaioli A
J Oncol Pharm Pract; 2011 Sep; 17(3):288-91. PubMed ID: 20926454
[TBL] [Abstract][Full Text] [Related]
19. Capecitabine (Xeloda) as monotherapy in advanced breast and colorectal cancer: effectiveness and side-effects.
Stathopoulos GP; Koutantos J; Lazaki H; Rigatos SK; Stathopoulos J; Deliconstantinos G
Anticancer Res; 2007; 27(3B):1653-6. PubMed ID: 17595791
[TBL] [Abstract][Full Text] [Related]
20. Medullary thyroid cancer treated by capecitabine.
Labidi SI; Gravis G; Tarpin C; Brun V; Viens P
Anticancer Drugs; 2007 Aug; 18(7):831-4. PubMed ID: 17581307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
